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This commentary addresses the article by Berman, et al. on reproductive health trends in Israel potentially related to
endocrine disrupting chemicals (EDCs) and on associated health policy decisions in Israel to prevent long-term
effects from exposure to EDCs. There are intensive, ongoing research efforts in the US that will provide additional
guidance on this issue in the future. The commentary also notes and commends the growing capacity and
resources for environmental health work in government and academia in Israel.Surveillance of disease is essential to public health; it is
how we know about the many problems we face, both
for infectious and chronic diseases. For environmental
health though, every case that is counted represents a
failure to have anticipated, ascertained, or prevented the
causal environmental exposure.
My career at CDC began with the study of fatal liver
cancer (Surveillance of disease is essential to public
health; it is how we know about the many problems we
face, both for infectious and chronic diseases. For envir-
onmental health though, every case that is counted
represents a failure to have anticipated, ascertained, or
prevented the causal environmental exposure.angiosar-
coma) in vinyl chloride polymerization workers and of
lead poisoning in children. The first of hundreds of cases
of liver cancer caused by vinyl chloride was detected in
1974, thirty two years after this production process was
introduced and decades too late for tens of thousands of
workers already significantly exposed. Similarly, the huge
impact of leaded gasoline was noted in the early 1980s,
more than a half century after leaded gasoline came into
widespread use and generations of children were signifi-
cantly exposed.
We must look at surveillance data for mortality, inci-
dence of disease, preclinical biologic changes, and asso-
ciated risk factors; there is much to be learned in this
work. At the same time, for assessing risk from chemical
exposures, whole scientific disciplines have developed in
areas such as hazard identification, exposure analysis,Correspondence: hxfalk@gmail.com
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reproduction in any medium, provided the orrisk characterization, comparative toxicology, and bio-
monitoring to proactively prevent exposure to toxic che-
micals. Because there are many scientific challenges and
also because the economic stakes are often very large,
the analytic protocols have become very detailed and ex-
pensive, and the regulatory processes are often very
complex.
Endocrine disrupting chemicals (EDCs) are at the cut-
ting edge of this scientific and public health challenge.
There are scores if not hundreds of chemicals to test,
often at very low doses. The health effects may be very
subtle or the chemicals may only slightly modify the
body’s hormonal balance—but of course this may be
enough for significant human health effects, especially if
one may be exposed to dozens of chemicals possibly
having cumulative effects. And much of our historic or
standard toxicologic testing regimens, heavily focused on
issues like carcinogenesis and teratogenesis, need to be
updated.
Berman and colleagues, in this issue of the IJHPR [1],
have done a thorough evaluation of the reproductive
health data in Israel that one might expect to be affected
by EDCs. They have looked at national databases such
as the cancer registry, the birth defects surveillance sys-
tem, and IDF screening examination results, and they
have also looked at specific studies done in Israel related
to issues such as in vitro fertilization, sperm tests, and
specific birth defects. Their conclusion is very carefully
stated: the data provide some evidence of adverse repro-
ductive trends, but much of the evidence is limited. This
brings us to the heart of the matter: what next? Balan-
cing between the very conservative approach of relyingis an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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reliable data and the alternative approach of hewing to a
very strong evidence base before taking action, the
authors have outlined the thoughtful approach being
taken in Israel to address this issue. They have also out-
lined a very appropriate plan of action to continue to
collect data in Israel so they can be abreast of any
changes occurring within the country. This is all a very
well reasoned and careful approach to a difficult chal-
lenge and the authors should be commended for their
work in this area.
There are efforts underway in the US that will provide
helpful data in the future. The EPA has established the
Endocrine Disruptor Screening Program [2] to substan-
tially increase the quantity, quality, and timeliness of
toxicity testing for EDCs; at the same time, the EPA
Office of Research and Development has a strong focus
on developing new and expedited testing approaches for
EDCs [3], in line with the recommendations of the Na-
tional Academy of Sciences [4]. The Centers for Disease
Control and Prevention (CDC) is conducting extensive
biomonitoring for EDCs as part of their nationally repre-
sentative testing of the US population [5], and other
parts of the US government, such as the NIH, also very
committed to research in this area.
From the perspective of a distant but interested and
engaged colleague, it is very gratifying to see the clear
growth in environmental health expertise in Israel exem-
plified by this article. It is exciting to see a growing
organizational locus for such work in the Ministry of
Health, as well as new links with scientific investigators
in major Israeli universities. This is a real tribute to the
leadership in the Ministry in recent years for supporting
these endeavors. Certainly, there are many challenging
environmental health issues to be addressed in Israel, in-
cluding air and water pollution and the safe handling of
toxic chemicals, and strong programs in government
and academia will be needed for sound science and pol-
icy development.
Finally, one doesn’t generally focus on the Acknowl-
edgments Section when writing a Commentary or Edi-
torial, but there is something remarkable here: the
Environment and Health Fund (http://www.ehf.org.il/) is
cited 4 times. As a member of the technical advisory
committee which initially evaluated the need for greater
capacity in Israel devoted to environmental health, and
as a keen observer of the process over the last 6–7 years,
I would like to recognize the foresight and good judg-
ment of Yad Hanadiv in initiating this effort and the dis-
ciplined approach and good work of the Environment
and Health Fund in implementing this program.Competing interests
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